Related Experiment Video

Updated: Aug 19, 2026

Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Phosphorylated retinoblastoma protein complexes with pp32 and inhibits pp32-mediated apoptosis

Onikepe Adegbola1, Gary R Pasternack

  • 1Division of Molecular Pathology, Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

The Journal of Biological Chemistry
|February 18, 2005
PubMed

Insights

The retinoblastoma protein (Rb) interacts with pp32, inhibiting its pro-apoptotic activity. This interaction promotes cancer cell proliferation and survival, offering a new understanding of tumor suppressor gene function in cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The retinoblastoma gene product (Rb) is a tumor suppressor involved in cell cycle regulation and apoptosis.
  • Rb inactivation in cancer occurs through mutation or altered phosphorylation, with distinct effects on apoptosis.
  • Hyperphosphorylated Rb's role in promoting cell survival is not fully understood, but it may involve sequestering pro-apoptotic factors.

Purpose of the Study:

  • To investigate the interaction between hyperphosphorylated Rb and the pro-apoptotic nuclear phosphoprotein pp32 (ANP32A).
  • To determine the functional consequences of the Rb-pp32 interaction on apoptosis and cell proliferation.

Main Methods:

  • Co-immunoprecipitation assays to detect protein-protein interactions.
  • Analysis of pp32 and Rb expression in cancer cells.
  • Functional assays to assess apoptosis and proliferation rates.

Main Results:

  • Hyperphosphorylated Rb specifically interacts with pp32, but not with related proteins pp32r1 and pp32r2.
  • The interaction between pp32 and Rb inhibits pp32's pro-apoptotic activity.
  • Rb-pp32 interaction was shown to stimulate cancer cell proliferation.

Conclusions:

  • Cancer cells can achieve a proliferative and survival advantage by inactivating Rb through hyperphosphorylation.
  • The interaction between hyperphosphorylated Rb and pp32 provides a mechanism for promoting tumor growth and resistance to apoptosis.
  • Targeting the Rb-pp32 interaction may offer novel therapeutic strategies for cancer treatment.

More Related Videos

Development and Application of Rapamycin-regulated Tyrosine Phosphatases06:56

Development and Application of Rapamycin-regulated Tyrosine Phosphatases

Published on: September 6, 2024

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...